Dextromethorphan hydrobromide, guaifenesin (glyceryl guaiacolate), terpin hydrate.
Each tablet contains dextromethorphan hydrobromide 15 mg, guaifenesin (glyceryl guaiacolate) 100 mg and terpin hydrate 130 mg.
For expectorant and relief of cough caused by common cold, bronchitis.
Adult dose and children age over 12 years, one tablet 3 to 4 times a day or prescribed by physician.
Method of Administration: Oral.
Symptoms: Nausea, vomiting, drowsiness, dizziness, blurred vision, nystagmus, ataxia, shallow respiration, urinary retention, stupor, toxic psychosis and coma.
Treatment: Symptomatic and supportive measures, gastric lavage, assisted respiration, vital sign monitoring, parenteral administration of naloxone and oral administration of activated charcoal.
Hypersensitivity to dextromethorphan or guaifenesin or terpin hydrate or any component of the formulation.
Terco-D should not be used for persistent or chronic cough such as with smoking, emphysema, asthma or cough accompanied by excessive secretions, unless directed by physician.
Terco-D should not be used in patients who received MAOI or after 2 weeks after discontinuing them.
Terco-D should not be given during pregnancy unless there are compelling medical reasons. Excretion in breast milk is unknown, nursing women must consult their doctor before using Terco-D.
Mild drowsiness, headache, rash, nausea, vomiting, confusion, constipation, GI disturbance, stomach pain, mild dizziness, urticaria.
May increase toxicity/effect of MAOI, amiodarone, fluoxetine, quinidine.
Store below 30°C. Protect from heat and moisture.
R05FA02 - opium derivatives and expectorants ; Belongs to the class of combinations of opium derivatives cough suppressants and expectorants. Used in the treatment of cough.
Terco-D tab
50 × 10's;500's
Sign Out
